id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-P-0033-0001,FDA,FDA-1997-P-0033,Acknowledgement Letter to University of Vermont,Other,ACK-Acknowledgement Letter,1997-12-02T05:00:00Z,1997,12,,,2024-11-01T01:00:57Z,,0,0,09000064805ca3ae
FDA-1992-N-0007-0004,FDA,FDA-1992-N-0007,FDA,Notice,NAD-Notice of Availability of Data,1997-12-02T05:00:00Z,1997,12,,,2008-05-16T23:31:45Z,,0,0,0900006480525bec
FDA-1992-N-0007-0005,FDA,FDA-1992-N-0007,Industry Supported Scientific and Educational Activities:  Guidance for Industry,Other,Guidance,1997-12-02T05:00:00Z,1997,12,,,2020-07-15T15:20:04Z,,0,0,0900006480525bf0
FDA-1992-N-0007-0006,FDA,FDA-1992-N-0007,Industry-Supported Scientific and Educational Activites,Supporting & Related Material,Guidance,1997-12-02T05:00:00Z,1997,12,,,2020-05-15T14:00:31Z,,0,0,0900006480525bf3
FDA-1996-N-0052-0001,FDA,FDA-1996-N-0052,FDA,Notice,NFR-Notice of Final Rule,1997-11-28T05:00:00Z,1997,11,,,2008-05-16T22:17:40Z,,0,0,09000064804fd270
FDA-1977-N-0018-0080,FDA,FDA-1977-N-0018,Acknowledgment Letter from FDA DDM re: Citizen Petition from Whitehall-Robins Healthcare (A Division of American Home Products Corporation) (Volume 1 of 4),Other,Acknowledgement Letter/Receipt,1997-11-28T05:00:00Z,1997,11,,,2019-02-05T13:16:24Z,,0,0,09000064805d9b9d
FDA-1978-N-0022-0019,FDA,FDA-1978-N-0022,Antifungal Drug Products for Over-the-Counter Human Use; External Analgesic Drug Products for Over-the-Counter Human Use; Skin Protectant Drug Products for Over-the-Counter Human Use; and Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Reopening of Administrative Records,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1997-11-21T05:00:00Z,1997,11,1997-11-21T05:00:00Z,1998-02-18T04:59:59Z,2020-02-04T12:52:44Z,97-30410,0,0,090000648055ebe7
FDA-1978-N-0027-0004,FDA,FDA-1978-N-0027,Antifungal Drug Products for Over-The-Counter Human Use; External Analgesic Drug Products for Over-The-Counter Human Use; Skin Protectant Drug Products for Over-The-Counter Human Use; and Topical Antimicrobial Drug Products for Over-The-Counter Human Use; Reopening of Administrative Records,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1997-11-21T05:00:00Z,1997,11,1997-11-19T05:00:00Z,1998-02-18T04:59:59Z,2019-08-01T15:43:51Z,97-30410,0,0,0900006480560ce9
FDA-1997-M-0021-0003,FDA,FDA-1997-M-0021,"Background Material re Ventritex, Inc.; Premarket Approval of the TVL® Lead System",Notice,Notice of Approval,1997-11-20T05:00:00Z,1997,11,1997-11-20T05:00:00Z,1997-12-20T04:59:59Z,2024-11-27T13:22:23Z,,0,0,09000064805ca10b
FDA-1997-M-0021-0002,FDA,FDA-1997-M-0021,"Background Material re Ventritex, Inc.; Premarket Approval of the TVL® Lead System",Notice,Notice of Approval,1997-11-20T05:00:00Z,1997,11,1997-11-20T05:00:00Z,1997-12-20T04:59:59Z,2024-11-27T13:21:44Z,,0,0,09000064805ca109
FDA-1997-M-0021-0001,FDA,FDA-1997-M-0021,"Ventritex, Inc.; Premarket Approval of the TVL® Lead System",Notice,Notice of Approval,1997-11-20T05:00:00Z,1997,11,1997-11-20T05:00:00Z,1997-12-20T04:59:59Z,2024-11-27T13:20:25Z,,0,0,09000064805ca107
FDA-1995-N-0029-0005,FDA,FDA-1995-N-0029,Food Labeling; Nutrient Content Claims: Definition for “High Potency” and Definitions of “Antioxidant” for Use in Nutrient Content Claims for Dietary Supplements and Conventional Foods; Correction,Rule,NCR-Notice of Correction,1997-10-30T05:00:00Z,1997,10,,,2008-06-17T16:55:54Z,,0,0,090000648055a53f
FDA-1980-N-0074-0061,FDA,FDA-1980-N-0074,HFD-560 to Buc & Beardsley,Other,LET-Letter,1997-10-24T04:00:00Z,1997,10,,,2008-05-30T22:52:54Z,,0,0,09000064805bb48c
FDA-1997-P-0035-0002,FDA,FDA-1997-P-0035,"Acknowledgement Letter from FDA DMB to Kleinfeld, Kaplan & Becker",Other,Acknowledgement Letter/Receipt,1997-10-22T04:00:00Z,1997,10,,,2025-01-28T18:51:06Z,,0,0,09000064805ca427
FDA-1997-P-0035-0001,FDA,FDA-1997-P-0035,"Acknowledgement Letter from FDA DMB to Kleinfeld, Kaplan & Becker",Other,Acknowledgement Letter/Receipt,1997-10-22T04:00:00Z,1997,10,,,2025-01-28T18:48:14Z,,0,0,09000064805ca41f
FDA-1997-P-0054-0002,FDA,FDA-1997-P-0054,"Acknowledgement Letter to the Center for Positron Emission Tomography, State University of New York at Buffalo, Department of Nuclear Medicine",Other,ACK-Acknowledgement Letter,1997-10-21T04:00:00Z,1997,10,,,2013-07-28T01:52:43Z,,0,0,09000064805cfd15
FDA-1993-N-0043-0005,FDA,FDA-1993-N-0043,(COPY)- Expedited Safety Reporting Requirements for Human Drug and Biological Products,Notice,Notice of Final Rule,1997-10-09T04:00:00Z,1997,10,1997-10-09T04:00:00Z,1997-12-09T04:59:59Z,2024-04-29T15:09:23Z,,0,0,09000064804fc456
FDA-1993-N-0043-0006,FDA,FDA-1993-N-0043,(COPY)- Expedited Safety Reporting Requirements for Human Drug and Biological Products,Notice,Notice of Final Rule,1997-10-09T04:00:00Z,1997,10,1997-10-09T04:00:00Z,1997-12-09T04:59:59Z,2024-04-29T15:10:12Z,,0,0,09000064804fc457
FDA-1993-N-0043-0004,FDA,FDA-1993-N-0043,Expedited Safety Reporting Requirements for Human Drug and Biological Products,Notice,Notice of Final Rule,1997-10-09T04:00:00Z,1997,10,1997-10-09T04:00:00Z,1997-12-09T04:59:59Z,2024-04-29T15:08:44Z,,0,0,09000064804fc455
FDA-1980-N-0074-0060,FDA,FDA-1980-N-0074,HFA-305 to Amway Corporation,Other,ACK-Acknowledgement Letter,1997-10-08T04:00:00Z,1997,10,,,2008-05-30T22:52:54Z,,0,0,09000064805bb48b
FDA-1995-N-0029-0004,FDA,FDA-1995-N-0029,Food Labeling; Nutrient Content Claims: Definition for “High Potency” and Definitions of “Antioxidant” for Use in Nutrient Content Claims for Dietary Supplements and Conventional Foods,Rule,NFR-Notice of Final Rule,1997-10-03T04:00:00Z,1997,10,,,2008-06-17T16:50:37Z,,0,0,090000648055a53a
FDA-1995-N-0029-0003,FDA,FDA-1995-N-0029,"Food Labeling; Requirements for Nutrient Content Claims, Health Claims, and Statements of Nutritional Support for Dietary Supplements",Rule,NFR-Notice of Final Rule,1997-10-01T04:00:00Z,1997,10,,,2008-06-17T16:59:19Z,,0,0,090000648055a536
FDA-1980-N-0036-0011,FDA,FDA-1980-N-0036,"Nonprecription Drugs Advisory Committee-April 15, 1997 Transcript",Other,TR-Transcript,1997-09-22T04:00:00Z,1997,9,,,2012-10-04T19:34:01Z,,0,0,09000064805b9489
FDA-1995-N-0054-0003,FDA,FDA-1995-N-0054,FDA,Notice,NEC-Notice of Extension,1997-09-17T04:00:00Z,1997,9,1997-09-17T04:00:00Z,1997-12-03T04:59:59Z,2008-05-16T22:28:01Z,,0,0,0900006480563bb8
FDA-1996-N-0027-0006,FDA,FDA-1996-N-0027,National Environmental Policy Act Proposed Revision of Policies and Procedures Correction,Rule,Correction,1997-09-16T04:00:00Z,1997,9,,,2014-01-19T17:23:25Z,,0,0,09000064804fb631
FDA-1991-F-0039-0001,FDA,FDA-1991-F-0039,Goldschmidt A.  G.,Notice,NWL-Notice of Withdrawl,1997-09-12T04:00:00Z,1997,9,,,2008-05-16T23:37:58Z,,0,0,090000648052a0c0
FDA-1980-N-0074-0059,FDA,FDA-1980-N-0074,Acknowledgement Letter from FDA HFA 305 to Tom's of Maine,Other,Acknowledgement Letter/Receipt,1997-09-12T04:00:00Z,1997,9,,,2022-05-25T20:47:17Z,,0,0,09000064805bb488
FDA-1980-N-0074-0058,FDA,FDA-1980-N-0074,Letter from FDA to Buc & Beardsly,Other,Letter(s),1997-09-10T04:00:00Z,1997,9,,,2022-05-25T16:50:43Z,,0,0,09000064805bb486
FDA-1980-N-0074-0057,FDA,FDA-1980-N-0074,Citizen Petition Approval Response Letter from FDA/CDER to Tom's of Maine,Other,Approval,1997-09-02T04:00:00Z,1997,9,,,2022-05-25T15:55:24Z,,0,0,09000064805bb484
FDA-1997-P-0003-0001,FDA,FDA-1997-P-0003,"FDA/CDER Response to Pitney, Hardin, Kipp & Szuch - Petition Approval",Other,Approval,1997-09-02T04:00:00Z,1997,9,,,2025-02-05T21:10:40Z,,0,0,09000064805c9547
FDA-1980-N-0074-0056,FDA,FDA-1980-N-0074,Memorandum of Telephone Conversation Between FDA and Tom's of Maine,Other,Memorandum,1997-08-29T04:00:00Z,1997,8,,,2022-05-16T21:06:03Z,,0,0,09000064805bb483
FDA-1989-N-0019-0002,FDA,FDA-1989-N-0019,"References from Specific Requirements on Content and Format of Labeling for Human Prescription Drugs; Addition of ""Geriatric Use"" Subsection in the Labeling",Notice,Notice of Final Rule,1997-08-28T04:00:00Z,1997,8,1997-08-28T04:00:00Z,1997-10-30T04:59:59Z,2024-01-16T20:19:42Z,,0,0,09000064804757c4
FDA-1989-N-0019-0001,FDA,FDA-1989-N-0019,"Specific Requirements on Content and Format of Labeling for Human Prescription Drugs; Addition of ""Geriatric Use"" Subsection in the Labeling",Notice,Notice of Final Rule,1997-08-28T04:00:00Z,1997,8,1997-08-28T04:00:00Z,1997-10-30T04:59:59Z,2024-01-17T02:00:08Z,97-22701,0,0,090000648047570f
FDA-1995-N-0054-0002,FDA,FDA-1995-N-0054,FDA,Notice,NPR-Notice of Proposed Rule-Making,1997-08-22T04:00:00Z,1997,8,,,2008-05-16T22:28:56Z,,0,0,0900006480563a27
FDA-1997-N-0041-0001,FDA,FDA-1997-N-0041,Prescription Drug Products; Levothyroxine Sodium,Notice,N-Notice,1997-08-20T04:00:00Z,1997,8,1997-08-20T04:00:00Z,1997-10-15T03:59:59Z,2009-01-24T19:53:02Z,,0,0,09000064805cfc01
FDA-1997-N-0041-0002,FDA,FDA-1997-N-0041,Prescription Drug Products; Levothyroxine Sodium [re FDA-1997-N-0041-0001,Notice,N-Notice,1997-08-20T04:00:00Z,1997,8,1997-08-20T04:00:00Z,1997-10-15T03:59:59Z,2009-01-24T19:55:06Z,,0,0,09000064805cfc03
FDA-1992-F-0035-0003,FDA,FDA-1992-F-0035,Reference 3- Regarding  Indirect Food Additives: Adhesives and Components of Coatings,Notice,Notice of Final Rule,1997-08-19T04:00:00Z,1997,8,1997-08-19T04:00:00Z,1997-09-12T03:59:59Z,2024-03-13T17:41:54Z,,0,0,0900006480528697
FDA-1992-F-0035-0002,FDA,FDA-1992-F-0035,Reference 1- Regarding  Indirect Food Additives: Adhesives and Components of Coatings,Notice,Notice of Final Rule,1997-08-19T04:00:00Z,1997,8,1997-08-19T04:00:00Z,1997-09-12T03:59:59Z,2024-03-13T17:42:18Z,,0,0,0900006480528696
FDA-1992-F-0035-0001,FDA,FDA-1992-F-0035,Reference 2-   Regarding  Indirect Food Additives: Adhesives and Components of Coatings,Notice,Notice of Filing,1997-08-19T04:00:00Z,1997,8,1997-08-19T04:00:00Z,1997-09-12T03:59:59Z,2024-03-13T17:42:49Z,,0,0,090000648052868b
FDA-1997-D-0048-0001,FDA,FDA-1997-D-0048,Draft Guidance for Industry; Consumer-Directed Broadcast Advertisements; Availability,Notice,Notice of Data Availability,1997-08-18T04:00:00Z,1997,8,1997-08-18T04:00:00Z,1997-10-15T03:59:59Z,2024-01-26T02:01:04Z,97-21291,0,0,09000064805cfc9f
FDA-1997-N-0019-0021,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca03e
FDA-1997-N-0019-0022,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:37Z,,0,0,09000064805ca03f
FDA-1997-N-0019-0008,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca031
FDA-1997-N-0019-0011,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca034
FDA-1997-N-0019-0016,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca039
FDA-1997-N-0019-0019,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca03c
FDA-1997-N-0019-0001,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca02a
FDA-1997-N-0019-0017,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:37Z,,0,0,09000064805ca03a
FDA-1997-N-0019-0020,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca03d
FDA-1997-N-0019-0003,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:37Z,,0,0,09000064805ca02c
FDA-1997-N-0019-0012,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca035
FDA-1997-N-0019-0002,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:37Z,,0,0,09000064805ca02b
FDA-1997-N-0019-0006,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:37Z,,0,0,09000064805ca02f
FDA-1997-N-0019-0014,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca037
FDA-1997-N-0019-0009,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca032
FDA-1997-N-0019-0013,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca036
FDA-1997-N-0019-0015,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca038
FDA-1997-N-0019-0004,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:37Z,,0,0,09000064805ca02d
FDA-1997-N-0019-0007,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca030
FDA-1997-N-0019-0010,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:37Z,,0,0,09000064805ca033
FDA-1997-N-0019-0018,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca03b
FDA-1997-N-0019-0005,FDA,FDA-1997-N-0019,"Duramed Pharm, Inc/Barr Labs., Inc",Notice,NPH-Notice of Opportunity of Hearing,1997-08-13T04:00:00Z,1997,8,1997-08-13T04:00:00Z,1997-09-09T03:59:59Z,2008-05-16T22:00:36Z,,0,0,09000064805ca02e
FDA-1980-N-0074-0055,FDA,FDA-1980-N-0074,HFD-560 to Buc & Beardsley,Other,LET-Letter,1997-08-08T04:00:00Z,1997,8,,,2008-05-30T22:53:16Z,,0,0,09000064805bb482
FDA-1997-P-0353-0003,FDA,FDA-1997-P-0353,"Luitpold Pharmaceuticals, Inc., (Arent Fox) - Amendment (Citizen Petition)",Other,AMD-Amendment,1997-08-08T04:00:00Z,1997,8,,,2024-11-12T04:54:59Z,,1,0,0900006480b336f6
FDA-1996-N-0027-0005,FDA,FDA-1996-N-0027,National Environmental Policy Act Proposed Revision of Policies and Procedures Pages 101 Thru 157,Rule,Final Rule,1997-08-04T04:00:00Z,1997,8,1997-08-04T04:00:00Z,1997-07-30T03:59:59Z,2014-01-19T17:24:33Z,,0,0,09000064804fb630
FDA-1996-N-0027-0004,FDA,FDA-1996-N-0027,National Environmental Policy Act Proposed Revision of Policies and Procedures Pages 1 Thru 100,Rule,Final Rule,1997-08-04T04:00:00Z,1997,8,1997-08-04T04:00:00Z,1997-07-30T03:59:59Z,2014-01-19T17:24:19Z,,0,0,09000064804fb62f
FDA-1997-N-0058-0001,FDA,FDA-1997-N-0058,FDA,Notice,NHC-Notice of Hearing Before Commissioner,1997-08-04T04:00:00Z,1997,8,1997-08-04T04:00:00Z,1997-11-13T04:59:59Z,2008-05-16T22:01:12Z,,0,0,09000064805d0252
FDA-1997-P-0026-0001,FDA,FDA-1997-P-0026,Acknowledgement Letter to Center for Science in the Public Interest,Other,ACK-Acknowledgement Letter,1997-08-01T04:00:00Z,1997,8,,,2008-06-24T22:54:25Z,,0,0,09000064805ca170
FDA-1997-P-0013-0001,FDA,FDA-1997-P-0013,"Acknowledgment Letter from FDA DMB to Cooper & Carvin, PLLC",Other,Acknowledgement Letter/Receipt,1997-07-31T04:00:00Z,1997,7,,,2024-10-02T01:00:48Z,,0,0,09000064805c9b37
FDA-1997-N-0060-0001,FDA,FDA-1997-N-0060,Animal Drug Availability Act; Medicated Feed Mill Licenses,Notice,NPR-Notice of Proposed Rule-Making,1997-07-31T00:00:00Z,1997,7,1997-07-30T04:00:00Z,1997-10-29T04:59:59Z,2025-05-15T16:22:19Z,97-19820,0,0,09000064805d02f0
FDA-1997-M-0062-0001,FDA,FDA-1997-M-0062,Perclose Inc.,Notice,NAL-Notice of Approval,1997-07-14T04:00:00Z,1997,7,1997-07-14T04:00:00Z,1997-08-08T03:59:59Z,2008-05-16T22:00:17Z,,0,0,09000064805d0322
FDA-1997-A-0012-0001,FDA,FDA-1997-A-0012,"HFA-305 to Burditt & Razius, Chartered",Other,ACK-Acknowledgement Letter,1997-07-11T04:00:00Z,1997,7,,,2008-05-16T21:58:42Z,,0,0,09000064805c9b0d
FDA-1978-N-0018-0460,FDA,FDA-1978-N-0018,Acknowledgment Letter from FDA DDM to Schering-Plough Healthcare Products,Other,Acknowledgement Letter/Receipt,1997-07-08T04:00:00Z,1997,7,,,2019-07-23T16:04:36Z,,0,0,090000648055a8bb
FDA-1997-P-0022-0002,FDA,FDA-1997-P-0022,Acknowledgement Letter from FDA DMB to Hogan & Hartson L.L.P.,Other,Acknowledgement Letter/Receipt,1997-07-02T04:00:00Z,1997,7,,,2025-02-12T19:23:01Z,,0,0,09000064805ca12d
FDA-1997-P-0022-0003,FDA,FDA-1997-P-0022,Acknowledgement Letter from FDA DMB to Hogan & Hartson L.L.P.,Other,Acknowledgement Letter/Receipt,1997-07-02T04:00:00Z,1997,7,,,2025-02-12T19:28:19Z,,0,0,09000064805ca12e
FDA-1993-P-0037-0002,FDA,FDA-1993-P-0037,"Acknowledgement Letter from FDA DMB to Wiley, Rein & Fielding",Other,Acknowledgement Letter/Receipt,1997-07-02T04:00:00Z,1997,7,,,2025-01-28T14:48:40Z,,0,0,09000064804fbefb
FDA-1997-P-0022-0001,FDA,FDA-1997-P-0022,Acknowledgement Letter from FDA DMB to Hogan & Hartson L.L.P.,Other,Acknowledgement Letter/Receipt,1997-07-01T04:00:00Z,1997,7,,,2025-02-12T19:19:47Z,,0,0,09000064805ca111
FDA-1997-P-0044-0001,FDA,FDA-1997-P-0044,"Acknowledgment Letter from FDA DDM to McDermont, Will and Emery",Other,Acknowledgement Letter/Receipt,1997-06-26T04:00:00Z,1997,6,,,2017-08-17T17:11:22Z,,0,0,09000064805cfc71
FDA-1996-P-0246-0005,FDA,FDA-1996-P-0246,Interim Response Letter from FDA CFSAN to Chocolate Manufacturers Association (CMA) and National Confectioners Association (NCA),Other,Letter(s),1997-06-23T04:00:00Z,1997,6,2014-02-20T05:00:00Z,,2014-02-20T13:41:21Z,,0,0,0900006480503974
FDA-1997-P-0032-0001,FDA,FDA-1997-P-0032,"Acknowledgement Letter from FDA DMB to Cohen, Pontani, Lieberman & Pavane",Other,Acknowledgement Letter/Receipt,1997-06-18T04:00:00Z,1997,6,,,2024-09-11T01:00:41Z,,0,0,09000064805ca395
FDA-1997-P-0002-0001,FDA,FDA-1997-P-0002,"Acknowledgement Letter from FDA DMB to Olsson, Frank & Weeda, P.C.",Other,Acknowledgement Letter/Receipt,1997-06-12T04:00:00Z,1997,6,,,2025-01-29T02:01:01Z,,0,0,09000064805c953a
FDA-1995-S-0039-0030,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1997-06-08T04:00:00Z,1997,6,2008-09-28T04:00:00Z,,2016-09-30T14:19:47Z,,0,0,090000648055c2f3
FDA-1995-N-0054-13910,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:32:00Z,,0,0,090000648056b92d
FDA-1995-N-0054-13901,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:27:51Z,,0,0,090000648056b90e
FDA-1995-N-0054-13926,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:32:00Z,,0,0,090000648056b94f
FDA-1995-N-0054-13916,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:31:17Z,,0,0,090000648056b93a
FDA-1995-N-0054-13917,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:27:51Z,,0,0,090000648056b93c
FDA-1995-N-0054-13906,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:30:32Z,,0,0,090000648056b922
FDA-1995-N-0054-13902,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:33:27Z,,0,0,090000648056b913
FDA-1995-N-0054-13918,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:28:40Z,,0,0,090000648056b93f
FDA-1995-N-0054-0001,FDA,FDA-1995-N-0054,FDA,Notice,NPR-Notice of Proposed Rule-Making,1997-06-06T04:00:00Z,1997,6,1997-06-06T04:00:00Z,1997-08-19T03:59:59Z,2008-05-16T22:32:03Z,,0,0,090000648056205b
FDA-1995-N-0054-13904,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:33:27Z,,0,0,090000648056b918
FDA-1995-N-0054-13933,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:28:40Z,,0,0,090000648056b97c
FDA-1995-N-0054-13908,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:33:27Z,,0,0,090000648056b927
FDA-1995-N-0054-13905,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:30:32Z,,0,0,090000648056b91a
FDA-1995-N-0054-13923,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:29:25Z,,0,0,090000648056b94a
FDA-1995-N-0054-13927,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:31:17Z,,0,0,090000648056b951
FDA-1995-N-0054-13937,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:29:25Z,,0,0,090000648056b986
FDA-1995-N-0054-13941,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:27:53Z,,0,0,090000648056b98e
FDA-1995-N-0054-13940,FDA,FDA-1995-N-0054,Background Information to NPR1,Supporting & Related Material,BKG-Background Material,1997-06-06T04:00:00Z,1997,6,,,2008-05-16T22:32:45Z,,0,0,090000648056b98c